Cargando…

Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma

BACKGROUND: Despite remarkable advancements in cancer immunotherapy, the overall response rate to anti-programmed cell death-1 (anti-PD-1) therapy in hepatocellular carcinoma (HCC) patients remains low. Our previous study has demonstrated the critical role of CacyBP/SIP (Calcyclin-Binding Protein an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jialiang, Zhang, Xiaoyu, Ma, Xinyi, Chen, Dongmei, Cai, Meina, Xiao, Lexin, Li, Jing, Huang, Zexuan, Huang, Yuehua, Lian, Yifan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652496/ https://www.ncbi.nlm.nih.gov/pubmed/37968706 http://dx.doi.org/10.1186/s13046-023-02885-w

Ejemplares similares

CacyBP/SIP promotes the proliferation of colon cancer cells
por: Zhai, Huihong, et al.
Publicado: (2017)

The CacyBP/SIP Protein is Sumoylated in Neuroblastoma NB2a Cells
por: Wasik, Urszula, et al.
Publicado: (2013)

Up-regulation of CacyBP/SIP during rat breast cancer development
por: Kilańczyk, Ewa, et al.
Publicado: (2012)

MAP kinase p38 is a novel target of CacyBP/SIP phosphatase
por: Topolska-Woś, Agnieszka M., et al.
Publicado: (2017)

The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells
por: Feng, Shanshan, et al.
Publicado: (2018)

CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma
por: Zhao, Ming, et al.
Publicado: (2020)

HSP90 Co-Chaperone, CacyBP/SIP, Protects α-Synuclein from Aggregation
por: Bohush, Anastasiia, et al.
Publicado: (2020)

Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression
por: Zheng, Hanxiong, et al.
Publicado: (2021)

Stress-Dependent Changes in the CacyBP/SIP Interacting Protein S100A6 in the Mouse Brain
por: Bartkowska, Katarzyna, et al.
Publicado: (2017)

Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP
por: Chu, Zhili, et al.
Publicado: (2018)

S100A6 Protein Negatively Regulates CacyBP/SIP-Mediated Inhibition of Gastric Cancer Cell Proliferation and Tumorigenesis
por: Ning, Xiaoxuan, et al.
Publicado: (2012)

The Effect of CacyBP/SIP on the Phosphorylation of ERK1/2 and p38 Kinases in Clear Cell Renal Cell Carcinoma
por: Smereczańska, Magdalena, et al.
Publicado: (2023)

Ageing-related changes in the levels of β-catenin, CacyBP/SIP, galectin-3 and immunoproteasome subunit LMP7 in the heart of men
por: Kasacka, Irena, et al.
Publicado: (2020)

Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human ageing hearts
por: Piotrowska, Żaneta, et al.
Publicado: (2018)

Comparative Assessment of the WNT/β-Catenin Pathway, CacyBP/SIP, and the Immunoproteasome Subunit LMP7 in Various Histological Types of Renal Cell Carcinoma
por: Piotrowska, Żaneta, et al.
Publicado: (2020)

CACYBP knockdown inhibits progression of prostate cancer via p53
por: Li, Qiang, et al.
Publicado: (2022)

Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

Correction for: The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2019)

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
por: Wang, Xueping, et al.
Publicado: (2020)

CACYBP Enhances Cytoplasmic Retention of P27(Kip1) to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation
por: Lian, Yi-Fan, et al.
Publicado: (2019)

Overexpressing CCT6A Contributes To Cancer Cell Growth By Affecting The G1-To-S Phase Transition And Predicts A Negative Prognosis In Hepatocellular Carcinoma
por: Zeng, Guofen, et al.
Publicado: (2019)

COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls
por: Regalla, Dinesh, et al.
Publicado: (2022)

Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023)

Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma
por: Chen, Lubiao, et al.
Publicado: (2019)

High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
por: Park, Dohyun, et al.
Publicado: (2019)

Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage
por: Huang, Tong-Yi, et al.
Publicado: (2020)

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
por: Lian, Shu, et al.
Publicado: (2019)

Reply to Campagna and Caci: Taking for Granted Conclusions from Studies that Cannot Prove Causality of Respiratory Symptoms and Vaping
por: Xie, Wubin, et al.
Publicado: (2022)

Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage
por: Hong, Yuan, et al.
Publicado: (2021)

Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia
por: Melo Garcia, Luciana, et al.
Publicado: (2021)

Blockage of lamin-A/C loss diminishes the pro-inflammatory macrophage response
por: Mehl, Johanna L., et al.
Publicado: (2022)

Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)

Blockage of CX3CL1 Attenuates Platelet and Leukocyte Recruitment in Murine Hepatic I/R
por: Funken, Dominik, et al.
Publicado: (2022)

Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma
por: Huang, Yanlin, et al.
Publicado: (2018)

Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells
por: Wang, Jialiang, et al.
Publicado: (2017)

Complete bacterial filter blockage by a plastic film
por: Huang, Jiapeng, et al.
Publicado: (2012)

Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
por: Tzeng, Horng-Tay, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ch7dp33g0ettc63ta6b9mmorq0